Logo image of EDAP

EDAP TMS SA -ADR (EDAP) Stock Fundamental Analysis

NASDAQ:EDAP - US2683111072 - ADR

2.26 USD
+0.44 (+24.18%)
Last: 8/29/2025, 8:17:55 PM
2.1501 USD
-0.11 (-4.86%)
After Hours: 8/29/2025, 8:17:55 PM
Fundamental Rating

2

Taking everything into account, EDAP scores 2 out of 10 in our fundamental rating. EDAP was compared to 185 industry peers in the Health Care Equipment & Supplies industry. EDAP may be in some trouble as it scores bad on both profitability and health. EDAP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EDAP had negative earnings in the past year.
In the past year EDAP has reported a negative cash flow from operations.
EDAP had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: EDAP reported negative operating cash flow in multiple years.
EDAP Yearly Net Income VS EBIT VS OCF VS FCFEDAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of EDAP (-28.73%) is comparable to the rest of the industry.
EDAP's Return On Equity of -62.52% is in line compared to the rest of the industry. EDAP outperforms 45.41% of its industry peers.
Industry RankSector Rank
ROA -28.73%
ROE -62.52%
ROIC N/A
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
EDAP Yearly ROA, ROE, ROICEDAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

EDAP has a worse Gross Margin (41.41%) than 65.95% of its industry peers.
EDAP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EDAP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
EDAP Yearly Profit, Operating, Gross MarginsEDAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

EDAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
EDAP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EDAP has more shares outstanding
Compared to 1 year ago, EDAP has a worse debt to assets ratio.
EDAP Yearly Shares OutstandingEDAP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EDAP Yearly Total Debt VS Total AssetsEDAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

A Debt/Equity ratio of 0.21 indicates that EDAP is not too dependend on debt financing.
EDAP has a Debt to Equity ratio (0.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.35%
EDAP Yearly LT Debt VS Equity VS FCFEDAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

EDAP has a Current Ratio of 1.74. This is a normal value and indicates that EDAP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.74, EDAP is doing worse than 70.81% of the companies in the same industry.
EDAP has a Quick Ratio of 1.21. This is a normal value and indicates that EDAP is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.21, EDAP is not doing good in the industry: 69.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.21
EDAP Yearly Current Assets VS Current LiabilitesEDAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

EDAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.00%.
Looking at the last year, EDAP shows a small growth in Revenue. The Revenue has grown by 3.87% in the last year.
EDAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.38% yearly.
EPS 1Y (TTM)-14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.33%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%-9.06%

3.2 Future

EDAP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.55% yearly.
Based on estimates for the next years, EDAP will show a quite strong growth in Revenue. The Revenue will grow by 16.50% on average per year.
EPS Next Y-28.98%
EPS Next 2Y-3.94%
EPS Next 3Y8.18%
EPS Next 5Y20.55%
Revenue Next Year-9.47%
Revenue Next 2Y-5.21%
Revenue Next 3Y-0.01%
Revenue Next 5Y16.5%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EDAP Yearly Revenue VS EstimatesEDAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
EDAP Yearly EPS VS EstimatesEDAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EDAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDAP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDAP Price Earnings VS Forward Price EarningsEDAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDAP Per share dataEDAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.94%
EPS Next 3Y8.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EDAP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDAP TMS SA -ADR

NASDAQ:EDAP (8/29/2025, 8:17:55 PM)

After market: 2.1501 -0.11 (-4.86%)

2.26

+0.44 (+24.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-26 2025-08-26/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners41.73%
Inst Owner Change-8.58%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap83.85M
Analysts77.78
Price Target5.87 (159.73%)
Short Float %0.07%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.73%
Min EPS beat(2)-23.38%
Max EPS beat(2)50.84%
EPS beat(4)1
Avg EPS beat(4)-3.21%
Min EPS beat(4)-25.99%
Max EPS beat(4)50.84%
EPS beat(8)1
Avg EPS beat(8)-52.3%
EPS beat(12)3
Avg EPS beat(12)-276.3%
EPS beat(16)5
Avg EPS beat(16)-216.17%
Revenue beat(2)1
Avg Revenue beat(2)-4.81%
Min Revenue beat(2)-12.67%
Max Revenue beat(2)3.05%
Revenue beat(4)1
Avg Revenue beat(4)-6.78%
Min Revenue beat(4)-15.73%
Max Revenue beat(4)3.05%
Revenue beat(8)2
Avg Revenue beat(8)-6.98%
Revenue beat(12)4
Avg Revenue beat(12)-4.02%
Revenue beat(16)5
Avg Revenue beat(16)-3.82%
PT rev (1m)0%
PT rev (3m)76.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.14
P/FCF N/A
P/OCF N/A
P/B 2.08
P/tB 2.24
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS1.98
BVpS1.08
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.73%
ROE -62.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.41%
FCFM N/A
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 166.04%
Cap/Sales 6.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.21
Altman-Z N/A
F-Score3
WACC7.35%
ROIC/WACCN/A
Cap/Depr(3y)176.18%
Cap/Depr(5y)116.88%
Cap/Sales(3y)5.91%
Cap/Sales(5y)4.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.33%
EPS Next Y-28.98%
EPS Next 2Y-3.94%
EPS Next 3Y8.18%
EPS Next 5Y20.55%
Revenue 1Y (TTM)3.87%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%-9.06%
Revenue Next Year-9.47%
Revenue Next 2Y-5.21%
Revenue Next 3Y-0.01%
Revenue Next 5Y16.5%
EBIT growth 1Y-20.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.9%
EBIT Next 3Y-1.85%
EBIT Next 5YN/A
FCF growth 1Y6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.45%
OCF growth 3YN/A
OCF growth 5YN/A